GSK Stands By Nasal Drops In Response To German Safety Concerns
Executive Summary
Following adverse event concerns in Germany, GSK has defended the safety of its Otriven infant nasal drops.
You may also be interested in...
GSK Unveils Two-Year Plan For Consumer Split
GSK preparing to seize “a major opportunity to create a new leader in consumer h
GSK’s Proposal For Mouth Spray Nicorette Delayed By FDA Questions On Label
Glaxo plans to make changes FDA requested in Complete Response letter sent on 18 October, the agency’s deadline for acting on NDA for an oral spray that delivers 1 mg per spray of aqueous buffered nicotine solution for oromucosal use.
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.